Newly published data shows 90% efficacy only in small group who got half-dose first
* Coronavirus – latest updates
* See all our coronavirus coverage
The Oxford/AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed.
The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it. Continue reading...
http://dlvr.it/RnFGw0
Subscribe to:
Post Comments (Atom)
Chuka
By Chimamanda Ngozi Adichie , Fiction , THE NEW YORKER February 10, 2025 Photograph by Nakeya Brown for The New Yorker I have always long...

-
The making—and selling—of Coca-Cola. By E. J. Kahn, Jr. , THE NEW YORKER, Profiles February 6, 1959 Photograph by George Marks / Retrofile...
-
A tale of two hot dog vendors claims the top spot in this year’s voting, outpolling four other favorites. All five are presented here. Dec. ...
No comments:
Post a Comment